• Fri news: Pfizer’s $1B Chinese commitment. RFK Jr. and pharma. Eisai dials back Leqembi forecast. US diabetes burden increase. JNJ gets Varipulse approval. See more on our front page

New posts

Post thread…
What's new New posts New profile posts Latest activity
How is this company still around?
Replies
6
Views
1K
Indivior
anonymous
  • New replies moderating enabled
Annette Powers… doomed leader
Replies
248
Views
25K
Bristol-Myers Squibb
anonymous
Should have hired Ron
Replies
2
Views
156
Phathom Pharmaceuticals
anonymous
  • New replies moderating enabled
Karyopharm - oncology
Replies
1K
Views
239K
Biotech Startups
anonymous
Michelle Weese
Replies
25
Views
3K
Novartis
anonymous
Just fire Bourla and be done with it.
Replies
15
Views
2K
Pfizer
anonymous
Oncology pulse survey
Replies
5
Views
405
AstraZeneca
anonymous
Abbott Vascular Clonmel
Replies
4K
Views
1M
Abbott
Aimee Smith
Positioning
Replies
1
Views
49
Eli Lilly
anonymous
Co promote with Kowa pharmaceuticals
Replies
0
Views
11
Arcutis
anonymous
town hall
Replies
4
Views
747
Bristol-Myers Squibb
anonymous
Fond farewell to “retiring SA Directors”
Replies
177
Views
16K
Alcon
anonymous
Product
Replies
0
Views
29
Novo Nordisk
anonymous
CVM VEHICLES
Replies
1
Views
162
Johnson & Johnson
anonymous
Positioning
Replies
0
Views
30
Bausch & Lomb
anonymous
Layoffs Have Begun
Replies
65
Views
17K
Merck
anonymous
Best/Worst CV managers
Replies
16
Views
3K
Boehringer Ingelheim
anonymous
How 'bout that new law suit ladies
Replies
3K
Views
500K
Masimo
anonymous
Stressed
Replies
0
Views
40
Novo Nordisk
anonymous
Eisai dials back forecasts for Alzheimer's drug Leqembi | pharmaphorum
Replies
2
Views
91
Eisai
anonymous
Top Bottom
Back
Post thread…